CYCLERION THERAPEUTICS, INC. Proceeds from Divestiture of Businesses
CYCLERION THERAPEUTICS, INC. (CYCN) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-11-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2025-11-12
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2024-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2023-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for the quarter ending 2022-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2023 was $10.40M.
- CYCLERION THERAPEUTICS, INC. proceeds from divestiture of businesses for fiscal 2022 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $0.00 10-K/A · filed 2025-11-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $10.40M 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $10.40M 10-Q · filed 2024-11-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |